Myriad Genetics buy The Goldman Sachs Group, Inc.
Start price
07.05.25
/
50%
€4.00
Target price
07.05.26
€7.05
Performance (%)
0.00%
Price
08:55
?
Summary
This prediction is currently active. The_Goldman_Sachs_Gr's BUY prediction for Myriad Genetics is currently unchanged. This prediction currently runs until 07.05.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Myriad Genetics | -2.475% | -2.475% |
| iShares Core DAX® | -4.932% | -11.977% |
| iShares Nasdaq 100 | -2.634% | -2.218% |
| iShares Nikkei 225® | -4.733% | -10.900% |
| iShares S&P 500 | -2.544% | -3.540% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $14.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for MYGN provided by MarketBeat